DR硅油填充后并发白内障行超声乳化联合硅油取出

目的：探讨糖尿病视网膜病变硅油填充后并发白内障的超声乳化及人工晶状体（IOL）植入联合硅油取出术的临床疗效。 方法：糖尿病视网膜病变患者22例22眼硅油填充后并发白内障行超声乳化及IOL植入联合硅油取出术,均通过角膜透明切口植入软性IOL。 结果：患者19眼视力均在白内障超声乳化手术后视力较术前提高,其中0.1以上者13例,3例同术前视力;手术中后囊膜保持完整,均顺利植入软性可折叠IOL;5例术后不同程度发生角膜水肿,均在术后3~7d内消退。22例硅油均顺利取出。3例术后1mo内发现玻璃体腔积血,其中2例约4wk内玻璃体腔积血自行吸收,1例再行玻璃体手术去除积血联合眼内光凝。22例术后均未发现视网膜再脱离。 结论：糖尿病视网膜病变硅油填充眼并发性白内障的超声乳化IOL植入术联合硅油取出手术效果满意,可减少患者多次手术的痛苦。     

硅油取出联合白内障超声乳化及人工晶状体植入术疗效观察

目的探讨硅油充填眼术后并发性白内障行白内障超声乳化及人工晶体植入联合硅油取出术的临床效果。方法对19例(19只眼)硅油填充术后并发性白内障患者进行经睫状体扁平部切口取硅油联合白内障超声乳化及人工晶状体植入术。结果术后随访3-12个月(平均7个月)。手术后最佳矫正视力光感～眼前指数2只眼,0.02～0.1者4只眼,0.1～0.2者8只眼,0.2以上5只眼。1眼因视网膜脱离复发,经再次手术硅油充填后视网膜复位。1眼术后玻璃体出血,经药物治疗后出血吸收。所有患者均无角膜内皮失代偿、人工晶体移位、硅油残留等。结论硅油取出联合白内障超声乳化及人工晶状体植入术是安全、有效的。严把联合手术的适应症及具备相当的手术技巧是手术成功的关键所在。     

玻切联合硅油填充术后并发性白内障的手术治疗

探讨白内障超声乳化吸除+硅油取出+人工晶状体植入+后囊膜环形切除术治疗玻璃体切割联合硅油填充术后并发性白内障的疗效。 方法：回顾分析2007-11/2011-11玻璃体切割联合硅油填充术后白内障患者102例102眼,距离玻璃体手术时间3~9（平均6.1）mo,采用玻璃体腔灌注,先行白内障超声乳化手术,前房注入黏弹剂,行硅油置换,然后人工晶状体植入,环形后囊切开,观察术中、术后并发症,术后视力等。 结果：术后 4wk,102例102眼中,97眼视力不同程度提高,5眼术后视力无改善;后囊破裂2例,无晶状体核坠入玻璃体,无脉络膜脱离。 结论：玻璃体切割联合硅油填充术后行白内障超声乳化吸除+硅油取出+人工晶状体植入+后囊膜环形切除术治疗玻璃体切割联合硅油填充术后并发性白内障,可有效减少术中、术后并发症,同时避免二次手术所带来的风险。     

硅油填充眼并发性白内障手术探讨

目的探讨硅油充填眼术后并发性白内障行超声乳化联合硅油取出及人工晶状体植入术的临床效果。方法对26例（26眼）硅油填充术后并发性白内障进行超声乳化经睫状体平坦部切口取硅油联合折叠式人工晶状体植入术。术后随访4-15个月（平均8个月）。结果手术后最佳矫正视力：光感-眼前数指者2眼,0.02-0.1者5眼,〉0.1-0.2者11眼,≥0.3者8眼。1眼因视网膜脱离复发,经再次手术硅油充填后视网膜复位。所有患者均无角膜内皮失代偿、人工晶状体移位或硅油残留等。结论硅油填充眼合并白内障行超声乳化联合硅油取出及折叠式人工晶状体植入术能有效提高视力,减少手术次数,提高手术安全性。     

硅油取出联合白内障超声乳化术的临床探讨

目的 评估通过透明角膜切口完成白内障超声乳化及折叠式人工晶体植入联合经瞳孔前路硅油取出改良术的安全性及有效性。方法 对57例硅油充填眼完成白内障超声乳化后经瞳孔前路硅油取出联合折叠式人工晶体植入。结果 术后未发生明显角膜并发症,89.4%的病人（51例）未发生视网膜再脱离,复发性视网膜脱离6例（11.6%）,再次手术后成功复位。41例患者的术后视力改善。结论 白内障超声乳化及折叠式人工晶体植入联合硅油奴出改良术安全有效,可以最大限度地减少手术损伤。     

超声乳化联合经后囊硅油取出及人工晶状体植入术

目的 探讨超声乳化联合经后囊硅油取出和人工晶状体植入术治疗硅油填充眼白内障的效果.方法 超声乳化联合经后囊硅油取出和人工晶状体植入术治疗硅油眼合并白内障96例（96眼）.超声乳化吸出术后行后囊环形撕囊,经上方角膜缘切口进入后囊撕囊口取出硅油,植入人工晶状体.结果 术后随访3～6月,所有患者裸眼及矫正视力均较术前提高,人工晶状体居中.3例早期角膜水肿,3～5 d消失,2例视网膜再脱离行再次视网膜复位手术;5例高眼压联合用药后控制正常.结论 对硅油填充眼白内障,行超声乳化联合经后囊硅油取出和人工晶状体植入术,可减少手术次数,并降低手术风险.     

急性视网膜坏死综合征硅油填充术后硅油取出时机选择

目的观察急性视网膜坏死综合征(ARN)行玻璃体切除联合硅油填充术后硅油充填期间及硅油取出术后并发症,进而探讨硅油取出的适宜时机。方法对连续就诊的伴有视网膜脱离的48例(48只眼)ARN患者实施玻璃体切除视网膜复位联合硅油填充术,对于确认视网膜已经复位,没有活动性的增生病变及视网膜裂孔,并在视网膜变性区域补充激光光凝的所有患者经不同时长的硅油填充期后实施硅油取出术,回顾分析其硅油填充期间及硅油取出术后并发症如视网膜脱离、并发性白内障、继发性青光眼、角膜变性等的发生情况。结果硅油填充术后视力总体上较术前有明显提高;硅油填充时间为3~15个月,平均5.8个月。取出硅油之后,总体视力无明显改变;8例于取硅油术后随访期内发生视网膜再脱离;1例角膜变性的病例,在硅油取出之后无明显改变;5例并发性白内障取油时实施超声乳化联合人工晶状体植入术;6例发生脉络膜脱离经药物治疗后痊愈;24例在硅油取出之后晶状体混浊程度较硅油取出术前无明显改变;3例无晶状体眼患者取油术后裸眼视力下降,但最佳矫正视力同硅油取出术前。结论硅油填充及硅油取出术的并发症主要为视网膜再脱离、脉络膜脱离、并发性白内障、继发性青光眼、硅油乳化、角膜变性、低眼压等。对于ARN而言,硅油填充时限4~6月时取油术后视网膜再脱离的发生率较低,取油较为适宜。     

经角膜切口行白内障超声乳化联合硅油取出术临床观察

在玻璃体切割术后硅油充填眼中,并发性白内障是最常见的手术并发症。我院对2006年1月至2010年4月间玻璃体切割术后硅油充填眼白内障患者36例（36只眼）经透明角膜切口行白内障超声乳化、硅油取出、人工晶状体植入联合手术。一、资料与方法1.一般资料：采用经透明角膜切口行此联合手术36例     

硅油填充术后并发性白内障超声乳化人工晶状体植入术联合硅油取出的临床观察

目的:观察硅油填充术后并发性白内障行超声乳化人工晶状体植入术联合硅油取出的治疗效果。方法:回顾性分析了40例(41只眼)硅油填充术后并发白内障行超声乳化联合硅油取出及人工晶状体植入的病例资料,并随访5~18个月,分析其视力恢复情况及术中、术后并发症。结果:除3例因硅油取出术后视网膜脱离外,其余患者均有不同程度的视力增加。术中主要并发症为后囊膜破裂,术后的主要并发症为视网膜脱离。结论:硅油填充术后并发性白内障行超声乳化人工晶状体植入术联合硅油取出术是一种安全有效的方法。     

硅油填充眼并发性白内障的手术疗效观察

目的：观察玻璃体切割术后硅油填充眼并发白内障行超声乳化联合硅油取出及人工晶状体植入术的临床效果及安全性。方法：对32例32眼硅油填充术后并发白内障患者行超声乳化联合经睫状体平坦部切口取硅油及折叠式人工晶状体植入术。术后随访3～18（平均9）mo。结果：术后最佳矫正视力：光感～数指/眼前者3眼,0.02～0.1者10眼,〉0.1～0.2者12眼,≥0.3者7眼。所有患者均无视网膜脱离、角膜内皮失代偿、人工晶状体移位或硅油残留等。结论：白内障行超声乳化联合硅油取出及折叠式人工晶状体植入术治疗硅油填充眼并发性白内障安全、有效。     

硅油充填眼并发性白内障摘除和人工晶体植入

为探讨行玻璃体手术联合硅油充填术后并发性白内障的术式,对３２例３２眼硅油充填术后并发白内障进行手术,其中２６例行常规的晶体囊外摘除＋人工晶体入术,６例行小切口晶体超声乳化＋折叠式人工晶体植入术。结果：３２例术中保留完整的晶体后囊,顺利植入人工晶体,除３例有计划手术中取出硅油外,其他未发生硅油的流失,术后视网膜保持平复,未见其他与手术有关的并发症发生。结论：硅油性白内障须根据眼前段及晶体核硬化程度等情况选择不同的手术方式,术中须采取有效方法预防硅油滴进入前房或溢出,植入人工晶体有助于日后处理后发障和预防其他并发症的发生。     

睫状体平坦部硅油取出术联合超声乳化白内障摘除术短期效果观察

目的:观察硅油填充眼的白内障超声乳化联合睫状体平坦部硅油取出手术的治疗效果。方法:对2005-01/2007-01我院收治的24例24眼玻璃体切除术后硅油填充眼患者,实施白内障超声乳化联合睫状体平坦部硅油取出术,观察术后视力、并发症等。结果:术中发生视网膜脱离3例3眼(12%)。术后3mo最佳矫正视力>0.3者1眼(4%);0.12～0.3者16眼(67%);≤0.1者7眼(29%);植入人工晶状体21眼(88%);未植入人工晶状体3眼(12%)。结论:硅油填充眼的白内障超声乳化联合睫状体平坦部硅油取出术是安全有效的手术方式。     

Phacoemulsification combined with silicone oil removal through a posterior capsulorhexis

PURPOSE: To evaluate the technique of silicone oil removal through a posterior capsulorhexis combined with phacoemulsification and intraocular lens (IOL) implantation. SETTING: Dr. Rajendra Prasad Center for Ophthalmic Sciences, New Delhi, India. METHODS: Fifteen eyes of 15 patients had phacoemulsification with removal of silicone oil, which had been used for intraocular tamponade after a previous pars plana vitrectomy. Eyes with a stable retina were included in the series. In all eyes, the silicone oil was removed through a planned posterior capsulorhexis after phacoemulsification. The parameters evaluated were the primary diagnosis, duration between silicone oil instillation and phacoemulsification, type of cataract, preoperative and postoperative best corrected visual acuities (BCVAs), and complications such as frequency of retinal redetachment and secondary cataract. RESULTS: Vitreoretinal surgery with silicone oil instillation was performed for rhegmatogenous-tractional detachment resulting from Eales' disease in 6 eyes and from proliferative diabetic retinopathy in 2 eyes, for primary rhegmatogenous retinal detachment in 6 eyes, and for traumatic rhegmatogenous detachment in 1 eye. The mean duration between the silicone oil instillation and phacoemulsification was 7.5 months +/- 3.8 (SD). Fourteen eyes had posterior subcapsular cataract, and 10 had nuclear sclerosis. Preoperative BCVA was worse than 6/60 in all eyes. The BCVA was 6/60 or better in 9 eyes after a minimum follow-up of 6 months. Two eyes had choroidal detachment in the early postoperative period. No eye had vitreous hemorrhage, retinal redetachment, secondary cataract, clinically significant endothelial decompensation or macular edema, or a dislocated IOL. CONCLUSION: The results indicate that silicone oil removal through a posterior capsulorhexis during phacoemulsification is a viable option and can be performed in selected cases of cataract with previous silicone oil instillation and a stable retina.     

Phacoemulsification combined with silicone oil removal through the posterior capsulorhexis tear

PURPOSE: To evaluate phacoemulsification combined with silicone oil removal through the posterior capsulorhexis tear. METHOD: The records of 20 patients with cataract after silicone oil repair of retinal detachment with giant retinal tear or complicated by proliferative vitreoretinopathy were reviewed. All eyes underwent phacoemulsification, posterior capsulorhexis, aspiration of silicone oil with an irrigation-aspiration hand piece, and intraocular lens implantation into the capsular bag. Lens calculation was based on the fellow eye. The mean follow-up period after cataract surgery was 15.4 months. RESULTS: There were three recurrences of retinal detachment (15%). Transient corneal edema was noted in two eyes. Unpredictable refraction was the main problem, but the myopic refractive error was <4.5 diopters in all cases. CONCLUSION: Cataract extraction combined with silicone oil removal is an effective technique.     

Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy

PURPOSE: To determine the clinical outcomes of phacoemulsification and foldable intraocular lens (IOL) implantation combined with primary vitrectomy and silicone oil tamponade to treat severe proliferative diabetic retinopathy (PDR). SETTING: Department of Ophthalmology, Seoul National University College of Medicine, and Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea. METHODS: The results of combined cataract surgery and silicone oil injection in 20 eyes (20 patients) were retrospectively analyzed. All patients had tractional or tractional-rhegmatogenous retinal detachment and clinically significant lens opacities; none had previous intraocular surgery. An acrylic foldable IOL was implanted in the capsular bag or ciliary sulcus. RESULTS: Primary anatomic success was achieved in 90% of eyes. Functional success was attained in 60% of eyes after a mean follow-up of 7.6 months. The postoperative visual acuity improved in 60% of patients, was unchanged in 20%, and was worse in 20%. Silicone oil was removed in 80% of patients without complications after a mean of 3.4 months. The mean absolute value of the difference between the predicted refraction and postoperative refraction was 0.74 diopter (D) (range 0.03 to 1.74 D). CONCLUSION: Phacoemulsification and foldable IOL implantation combined with primary vitrectomy and silicone oil tamponade was performed safely with favorable anatomic and visual outcomes in eyes with severe PDR.     

硅油填充66例的临床分析

目的:探讨硅油填充原因及硅油填充时间与相关并发症的关系。方法:回顾分析总结66例70只硅油填充眼的临床资料及随访记录。结果:硅油填充的主要原因为常规孔源性视网膜脱离反复多次手术操作,其次是黄斑裂孔性视网膜脱离,再次为增生性糖尿病性视网膜病变。硅油平均填充时间10.5mo,硅油乳化发生率28.6%,高眼压发生率15.7%,角膜变性发生率2.9%,严重白内障的发生率46%。硅油取出后主要并发症是视网膜脱离复发。结论:在定期随访的情况下,可适当延长硅油在眼内的存留时间。取硅油时,保持玻璃体腔持续灌注,并根据视网膜情况行视网膜激光、眼内气体充填或再次行硅油填充等处理,可以减少硅油取出术后并发症的发生。     

硅油填充眼在不同时机行人工晶状体植入的屈光误差比较

目的:比较玻璃体切割硅油填充眼不同时机行白内障超声乳化并人工晶状体植入术后屈光误差。方法:回顾性分析选取2009-01/2011-12玻璃体切割硅油填充眼不同时机行白内障超声乳化并人工晶状体植入术51例51眼,其中A组17例行玻璃体切割硅油填充联合白内障超声乳化并人工晶状体植入术,术后3～6mo行硅油取出;B组13例行玻璃体切割术后硅油取出联合白内障超声乳化并人工晶状体植入术,C组21例硅油取出术后择期行白内障超声乳化并人工晶状体植入术,比较术后3mo时屈光误差情况。结果:三组平均绝对屈光误差值分别为(0.873±0.256)D,(0.828±0.134)D,(0.473±0.121)D,A组和B组之间差异无统计学意义(P>0.05),C组和A组及B组之间差异有统计学意义(P<0.05)。结论:A超眼轴测量计算人工晶状体度数,玻璃体切割硅油填充眼在取油后择期行白内障超声乳化并人工晶状体植入术屈光误差小。